Pharmena S.A.
Develops dietary supplements using its patented 1-MNA molecule to support healthy aging.
PHR | WAR
Overview
Corporate Details
- ISIN(s):
- PLPHRMN00011
- LEI:
- 259400RHT936BBKW0955
- Country:
- Poland
- Address:
- ŁÓDŹ GDAŃSKA 47/49, 90-729 ŁÓDŹ
- Website:
- https://www.pharmena.eu/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Pharmena S.A. is a biotechnology company specializing in the development and commercialization of innovative products based on its patented, proprietary 1-MNA molecule. This naturally occurring substance, a metabolite of vitamin B3, is foundational to the company's offerings, which aim to support healthy aging by regulating cellular metabolism. Following the strategic divestment of its dermo-cosmetics division, Pharmena now concentrates on the dietary supplements market, including its flagship Endotelio brand. The company is also expanding its research and development into new areas, such as advanced medical devices for wound care.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-08 13:56 |
Regulatory News Service
Zawarcie umowy na wykonanie badań biokompatybilności przyszłego wyrobu medyczne…
|
Polish | 1.6 KB | ||
| 2025-07-16 10:53 |
Regulatory News Service
Rozpoczęcie współpracy z Shop Apotheke w zakresie sprzedaży suplementów diety w…
|
Polish | 1.2 KB | ||
| 2025-07-07 10:12 |
Regulatory News Service
Zawarcie umowy na opracowanie dokumentacji oraz wytworzenie serii walidacyjnych…
|
Polish | 2.0 KB | ||
| 2025-06-25 16:52 |
Declaration of Voting Results & Voting Rights Announcements
PHR_Wykaz akcjonariuszy posiad. pow. 5% głosów na ZWZ w dniu 25 06 2025
|
Polish | 50.1 KB | ||
| 2025-06-25 16:52 |
Major Shareholding Notification
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na ZWZ w dniu 25…
|
Polish | 525 bytes | ||
| 2025-06-25 16:51 |
Board/Management Information
250625_Informacja dot Jacka Szwajcowskiego
|
Polish | 306.7 KB | ||
| 2025-06-25 16:51 |
Board/Management Information
250625_Informacja dot Zbigniewa Molenda
|
Polish | 224.2 KB | ||
| 2025-06-25 16:51 |
Board/Management Information
250625_Informacja dot. Anny Paczkowskiej
|
Polish | 239.0 KB | ||
| 2025-06-25 16:51 |
Board/Management Information
250625_Informacja dot Tomasz Filipiak
|
Polish | 192.5 KB | ||
| 2025-06-25 16:51 |
Board/Management Information
250625_Informacja dot Agnieszki Dziki
|
Polish | 146.7 KB | ||
| 2025-06-25 16:51 |
Board/Management Information
250625_Informacja dot Jacka Dauenhauera
|
Polish | 225.0 KB | ||
| 2025-06-25 16:51 |
Post-Annual General Meeting Information
Powołanie członków Rady Nadzorczej na nową kadencję - Content (PL)
|
Polish | 1.3 KB | ||
| 2025-06-25 16:50 |
Post-Annual General Meeting Information
Treść uchwał podjętych przez ZWZ PHARMENA S.A. w dniu 25 06 2025
|
Polish | 176.8 KB | ||
| 2025-06-25 16:50 |
Post-Annual General Meeting Information
Treść uchwał podjętych przez ZWZ PHARMENA S.A. w dniu 25.06.2025 r. - Content (…
|
Polish | 822 bytes | ||
| 2025-05-29 14:57 |
Board/Management Information
zal03_Oswiadczenie_Jacek_Szwajcowski.pdf
|
Polish | 646.9 KB |
Automate Your Workflow. Get a real-time feed of all Pharmena S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Pharmena S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
